alnylam
The Scientist, Process Sciences is responsible for developing, characterizing, and scaling biocatalytic processes, working with cross-functional teams and contract manufacturers to support drug candidate manufacturing. The role involves process development, transfer, and oversight, focusing on oligonucleotide and small molecule APIs.
Headquarters
Cambridge, Massachusetts, United States
Company Size
1001-5000 employees
Founded
2002
Alnylam is a biopharmaceutical company that has pioneered RNA interference (RNAi) therapeutics, an innovative class of medicines that treats diseases by silencing the genes that cause or contribute to them. The company develops RNAi-based medicines targeting both rare and prevalent diseases across multiple therapeutic areas, with approved products and a robust investigational pipeline. Driven by science and inspired by patients, Alnylam is committed to delivering transformational medicines that address diseases at their genetic source.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for alnylam.
Right around the average for this role
Associate Director - TSMS Laboratory
Eli Lilly and Company
Chemical Engineering Research & Development
MSD
Associate Principal Scientist, Discovery Pharmaceutical Sciences
Merck & Co., Inc.
Mixed Modality (Oligonucleotide) Principal Scientist
Eli Lilly and Company
Senior Scientist, Biocatalysis
MSD
Associate Principal Scientist, Discovery Pharmaceutical Sciences
Merck & Co., Inc.